Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

Head and Neck

Volumn 32, Issue 9, 2010, Pages 1195-1201

  Clay, Matthew R ^a   Tabor, Mark ^b   Owen, John Henry ^c   Carey, Thomas E ^c   Bradford, Carol R ^c   Wolf, Gregory T ^c   Wicha, Max S ^c   Prince, Mark E ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

aldehyde dehydrogenase; cancer stem cells; head and neck cancer; squamous cell cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; TUMOR MARKER;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SQUAMOUS CELL CARCINOMA;

AGED; ALDEHYDE DEHYDROGENASE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MICE, INBRED NOD; MIDDLE AGED; MODELS, ANIMAL; NEOPLASTIC STEM CELLS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954901231     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21315     Document Type: Article

References (28)

1. Jain S, Khuri FR, Shin DM,. Prevention of head and neck cancer: current status and future prospects. Curr Probl Cancer 2004; 28: 265-286.
2. Golub TR,. Genome-wide views of cancer. N Engl J Med 2001; 344: 601-602.
3. Reya T, Morrison SJ, Clarke MF, Weissman IL,. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
4. Pardal R, Clarke MF, Morrison SJ,. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902.
5. Al-Hajj M, Clarke MF,. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282.
6. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE,. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495-502.
7. Owens DM, Watt FM,. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev 2002; 3: 444-451.
8. Wicha MS, Liu S, Dontu G,. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006; 66: 1883-1890.
9. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667.
10. Kelly LM, Gilliland DG,. Genetics of myeloid leukemias. Ann Rev Gen Hum Gen 2002; 3: 179-198.
11. Li C, Lee CJ, Simeone DM,. Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009; 568: 161-173.
12. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
13. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
14. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100: 15178-15183.
15. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA,. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39: 193-206.
16. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
17. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978.
18. Duester G,. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2004; 267: 4315-4324.
19. Sophos NA, Vasiliou V,. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem-Biol Interact 2003; 143-144: 5-22.
20. Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006; 103: 11707-11712.
21. Armstrong L, Stojkovic M, Dimmick I, et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 2004; 22: 1142-1151.
22. Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162-2169.
23. Hess DA, Meyerrose TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 1648-1655.
24. Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103: 2332-2336.
25. Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005; 23: 752-760.
26. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
27. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-313.
28. Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.